Analgesics

Chemical Immunology and Allergy

Volumn 95, Issue , 2010, Pages 170-179

  Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZAPROPAZONE; CELECOXIB; CHOLINE MAGNESIUM TRISALICYLATE; DICLOFENAC; DICLOFENAC POTASSIUM; DIFLUNISAL; DIPYRONE; DOLBID; ETODOLAC; FENOPROFEN; FENOPROFEN CALCIUM; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETONAL; KETOPROFEN; KETOROLAC; MECLOFENAMATE SODIUM; MECLOFENAMIC ACID; MEFENAMIC ACID; MELOXICAM; NABUMETONE; NAPROXEN; NIMESULIDE; OLSALAZINE; OXAPROZIN; PARACETAMOL; PIROXICAM; SALAZOSULFAPYRIDINE; SALICYLATE SODIUM; SALSALATE; SULINDAC; TENOXICAM; TOLMETIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIA; ANAPHYLAXIS; ASTHMA; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; HUMAN; HYPERSENSITIVITY REACTION; NOSE POLYP; PRIORITY JOURNAL; RASH; REVIEW; RHINORRHEA; RHINOSINUSITIS; URTICARIA;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA, ASPIRIN-INDUCED; CYCLOOXYGENASE 1; DRUG HYPERSENSITIVITY; DYSPNEA; EICOSANOIDS; EOSINOPHILS; HUMANS; RHINITIS; SINUSITIS; URTICARIA;

EID: 77954851482     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000315950     Document Type: Review

References (27)

1. Vane JR, Botting RH (eds): Aspirin and Other Salicylates. London, Chapman & Hall, 1992, pp 3-17.
2. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971;231:232-234.
3. Samter M, Beers RF Jr: Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-983.
4. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirinsensitive patients. Br Med J 1975;1:67-69.
5. Settipane GA: Landmark commentary: history of aspirin intolerance. Allergy Proc 1990;11:251-252.
6. Szczeklik A, Sanak M: The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006;533:145-155.
7. Stevenson DD, Szczeklik A: Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006;118:773-786.
8. Szczeklik A, Nizankowska-Mogilnicka E, Sanak M: Hypersensitivity to aspirin and nonsteroidal antiinflammatory drugs; in Adkinson NF, Busse WW, Bochner BS, et al (eds): Middleton's Allergy, ed 7. St Louis, Mosby Elsevier, 2009, pp 1227-1243.
9. Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000;16:432-436.
10. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczyńska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, W?rl S, Dahl? B, Szczeklik A: EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007;62:1111-1118.
11. Szczeklik A: The cyclooxygenase theory of aspirininduced asthma. Eur Respir J 1990;3:588-593.
12. Szczeklik A, Sanak M: The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors. Clin Exp Allergy 2002;32:339-342.
13. Bavbek S, Dursun AB, Dursun E, Eryilmaz A, Misirligil Z: Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. Int Arch Allergy Immunol 2007;142:64-69.
14. Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin-induced asthma and its implications for clinical practice. BMJ 2004;328:434-437.
15. Baldassarre S, Schandene L, Choufani G, Michils A: Asthma attacks induced by low doses of celecoxib, aspirin and acetaminophen. J Allergy Clin Immunol 2006;117:215-217.
16. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A: Safety of cyclooxygenase-2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003;139:1577-1582.
17. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A: Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria. J Cutan Pathol 2004;31:323-329.
18. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A: Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004;113:771-775.
19. Mastalerz L, Sanak M, Gawlewicz A, Gielicz A, Faber J, Szczeklik A: Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma and urticaria. J Allergy Clin Immunol 2006;118:957-958.
20. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T: Intolerance to nonsteroidal anti-inflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996;98:678-685.
21. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60:276-284. (Pubitemid 8225955)
22. Czerniawska-Mysik G, Szczeklik A: Idiosyncrasy to pyrazolone drugs. Allergy 1981;36:381-384.
23. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, Ebner H, Ebner C: IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003;111:882-888.
24. Schneider CH, Kasper MF, de Weck AL, Rolli H, Angst BD: Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione crossreactivity relationships. Allergy 1987;42:597-603.
25. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M: Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998;28:1153-1158.
26. Schuster C, Wuthrich B: Anaphylactic drug reaction to celecoxib and sulfamethoxazole: cross-reactivity or coincidence? Allergy 2003;58:1072.
27. Fontaine C, Bousquet PJ, Demoly P: Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J All ergy Clin Immunol 2005;115:633-634.